Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for incb018424 (compound)
Most Correlated Studies
- Pro-B BAF-3 cells overexpressing MPL[W515L] and treated with JAK2 inhibitor INCB18424
- Dermal papilla cells from donors in spheres treated with tofacitinib or ruxolitinib
- Scalp skin biopsies of alopecia areata patients before and after treatment with ruxolitinib
- Skin post-5/6wk or 12wk of treatment with IL-15 pathway inhibitors or PBS following alopecia graft
- Skin from alopecia areata allografts treated with ruxolitinib or tofacitinib
Most Relevant Literature
- Cryptococcal meningoencephalitis associated with the long-term use of ruxolitinib.
- Hematologic Malignancies/Pediatric Malignancies. I. Ruxolitinib Therapy for Myelofibrosis and Polyc…
- Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best availabl…
- Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Panc…
- Varicella-zoster virus meningoencephalitis in a patient treated with ruxolitinib.
Most Relevant Clinical Trials
- INCB018424 in Patients With Advanced Hematologic Malignancies
- A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects…
- Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essen…
- Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastat…
- Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients
